346 related articles for article (PubMed ID: 27299710)
1. Distinct Responses of Stem Cells to Telomere Uncapping-A Potential Strategy to Improve the Safety of Cell Therapy.
Liu CC; Ma DL; Yan TD; Fan X; Poon Z; Poon LF; Goh SA; Rozen SG; Hwang WY; Tergaonkar V; Tan P; Ghosh S; Virshup DM; Goh EL; Li S
Stem Cells; 2016 Oct; 34(10):2471-2484. PubMed ID: 27299710
[TBL] [Abstract][Full Text] [Related]
2. Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.
Babizhayev MA; Yegorov YE
J Biomed Mater Res A; 2015 Dec; 103(12):3993-4023. PubMed ID: 26034007
[TBL] [Abstract][Full Text] [Related]
3. Neural tumor-initiating cells have distinct telomere maintenance and can be safely targeted for telomerase inhibition.
Castelo-Branco P; Zhang C; Lipman T; Fujitani M; Hansford L; Clarke I; Harley CB; Tressler R; Malkin D; Walker E; Kaplan DR; Dirks P; Tabori U
Clin Cancer Res; 2011 Jan; 17(1):111-21. PubMed ID: 21208905
[TBL] [Abstract][Full Text] [Related]
4. Regulation and Effect of Telomerase and Telomeric Length in Stem Cells.
Celtikci B; Erkmen GK; Dikmen ZG
Curr Stem Cell Res Ther; 2021; 16(7):809-823. PubMed ID: 32321410
[TBL] [Abstract][Full Text] [Related]
5. Platinum(II) phenanthroimidazole G-quadruplex ligand induces selective telomere shortening in A549 cancer cells.
Mancini J; Rousseau P; Castor KJ; Sleiman HF; Autexier C
Biochimie; 2016 Feb; 121():287-97. PubMed ID: 26724375
[TBL] [Abstract][Full Text] [Related]
6. Telomere and telomerase in stem cells.
Hiyama E; Hiyama K
Br J Cancer; 2007 Apr; 96(7):1020-4. PubMed ID: 17353922
[TBL] [Abstract][Full Text] [Related]
7. Reversible transformation and de-differentiation of human cells derived from induced pluripotent stem cell teratomas.
Kamada M; Mitsui Y; Matsuo T; Takahashi T
Hum Cell; 2016 Jan; 29(1):1-9. PubMed ID: 26069211
[TBL] [Abstract][Full Text] [Related]
8. Association of telomere length with authentic pluripotency of ES/iPS cells.
Huang J; Wang F; Okuka M; Liu N; Ji G; Ye X; Zuo B; Li M; Liang P; Ge WW; Tsibris JC; Keefe DL; Liu L
Cell Res; 2011 May; 21(5):779-92. PubMed ID: 21283131
[TBL] [Abstract][Full Text] [Related]
9. Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner.
Frink RE; Peyton M; Schiller JH; Gazdar AF; Shay JW; Minna JD
Oncotarget; 2016 May; 7(22):31639-51. PubMed ID: 27192120
[TBL] [Abstract][Full Text] [Related]
10. Engineering a humanized telomerase reverse transcriptase gene in mouse embryonic stem cells.
Cheng D; Zhao Y; Zhang F; Zhang J; Wang S; Zhu J
Sci Rep; 2019 Jul; 9(1):9683. PubMed ID: 31273310
[TBL] [Abstract][Full Text] [Related]
11. Immortalization of neural precursors when telomerase is overexpressed in embryonal carcinomas and stem cells.
Schwob AE; Nguyen LJ; Meiri KF
Mol Biol Cell; 2008 Apr; 19(4):1548-60. PubMed ID: 18256293
[TBL] [Abstract][Full Text] [Related]
12. Telomeres, senescence, and hematopoietic stem cells.
Zimmermann S; Martens UM
Cell Tissue Res; 2008 Jan; 331(1):79-90. PubMed ID: 17960423
[TBL] [Abstract][Full Text] [Related]
13. Endogenous Telomerase Reverse Transcriptase N-Terminal Tagging Affects Human Telomerase Function at Telomeres In Vivo.
Chiba K; Vogan JM; Wu RA; Gill MS; Zhang X; Collins K; Hockemeyer D
Mol Cell Biol; 2017 Feb; 37(3):. PubMed ID: 27872149
[TBL] [Abstract][Full Text] [Related]
14. Replicative senescence of hematopoietic stem cells during serial transplantation: does telomere shortening play a role?
Allsopp RC; Weissman IL
Oncogene; 2002 May; 21(21):3270-3. PubMed ID: 12032768
[TBL] [Abstract][Full Text] [Related]
15. Telomerase-mediated telomere elongation from human blastocysts to embryonic stem cells.
Zeng S; Liu L; Sun Y; Xie P; Hu L; Yuan D; Chen D; Ouyang Q; Lin G; Lu G
J Cell Sci; 2014 Feb; 127(Pt 4):752-62. PubMed ID: 24338368
[TBL] [Abstract][Full Text] [Related]
16. Consequences of telomere shortening during lifespan.
Henriques CM; Ferreira MG
Curr Opin Cell Biol; 2012 Dec; 24(6):804-8. PubMed ID: 23127607
[TBL] [Abstract][Full Text] [Related]
17. An intact putative mouse telomerase essential N-terminal domain is necessary for proper telomere maintenance.
Rousseau P; Khondaker S; Zhu S; Lauzon C; Mai S; Autexier C
Biol Cell; 2016 Apr; 108(4):96-112. PubMed ID: 26787169
[TBL] [Abstract][Full Text] [Related]
18. Method for selective ablation of undifferentiated human pluripotent stem cell populations for cell-based therapies.
Chour T; Tian L; Lau E; Thomas D; Itzhaki I; Malak O; Zhang JZ; Qin X; Wardak M; Liu Y; Chandy M; Black KE; Lam MP; Neofytou E; Wu JC
JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33830086
[TBL] [Abstract][Full Text] [Related]
19. In vitro aging of rat lung cells. Downregulation of telomerase activity and continuous decrease of telomere length are not incompatible with malignant transformation.
Petitot F; Lebeau J; Dano L; Lectard B; Altmeyer S; Levalois C; Chevillard S
Exp Cell Res; 2003 May; 286(1):30-9. PubMed ID: 12729792
[TBL] [Abstract][Full Text] [Related]
20. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells.
Marion RM; Strati K; Li H; Tejera A; Schoeftner S; Ortega S; Serrano M; Blasco MA
Cell Stem Cell; 2009 Feb; 4(2):141-54. PubMed ID: 19200803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
